MERCK FOUNDATION commits to long term partnership with Government of Tanzania
Share this story on:
Merck Foundation commits to build healthcare capacity and improve access to innovative and equitable healthcare solutions in Tanzania
H.E. Vice President of the United Republic of Tanzania, Dr Samia Suluhu Hassan (right) and Dr Rasha Kelej, CEO of Merck Foundation (left)
During the high level meeting between Her Excellency Vice President, Dr Samia Suluhu Hassan and Dr Rasha Kelej, the CEO of Merck Foundation, Merck Foundation commits to a long term partnership with the Government of Tanzania to build healthcare capacity and improve access to innovative and equitable healthcare solutions across the country as part of their CSR programs across Africa.
Merck Foundation will focus on providing one year and two years Surgical and Paediatric oncology fellowship program in India, Europe and University of Nairobi for Tanzanian doctors to improve the cancer care in the country. They will also focus on empowering infertile women through access to information, awareness, health, change of mind set and economic empowerment across the country through their ‘Merck more than a Mother’ campaign. “The prevalence of infertility is so high in Africa , one every four couple in reproductive age suffers from infertility and yet around 85% of those cases are due to untreated infectious disease which can prevented , henceraising awareness about prevention through local media and social media is very critical”, Rasha Kelej said.
From left to right: Ms. Maulidah Hassan, Assistant to the Vice President of the UnitedRepublic of Tanzania; Dr Nicholaus Stephen Mazuguni, MD, MMED(O&G) Embryology Training Alumni; Mr Leonard Saika, Program Director Merck Foundation; Dr Rasha Kelej ,CEO Merck Foundation and H.E. Dr Samia Suluhu Hassan, Vice President of the United Republic of Tanzania.
“Raising awareness about male infertility as the infertility affects women and men equally and yet women are the one who been solely blamed, discriminated and mistreated in their communities. The campaign will address this topic and encourage men to discuss openly their infertility and share the journey of infertility diagnosis and treatment with their wives”, Kelej added.
Dr Rasha Kelej, CEO of Merck Foundation (right); H.E. Vice President of the United Republic of Tanzania, Dr Samia Suluhu Hassan (left)
Her Excellency Vice President, Samia Suluhu Hassan commended the role Merck Foundation plays in healthcare capacity building in Africa and welcomes them to Tanzania. She added: “Tanzania welcomes Merck Foundation to the country, we are happy to partner with such reputable and serious organization top empower women and you, healthcare and science. I will personally work with you to empower these underprivileged womensocially and economically across Tanzania and the rest of the world to create a culture shift needed to respect and appreciate women as productive members in society weather they are mother or not.”
From left to right: Mr Leonard Saika, Program Director Merck Foundation; Dr Rasha Kelej, CEO of Merck Foundation and H.E. Vice President of the United Republic of Tanzania, Dr Samia Suluhu Hassan
The Merck Foundation, established in 2017, is the philanthropic arm of Merck KGaA Germany, aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to quality & equitable healthcare solutions in underserved communities, building healthcare and scientific research capacity and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website. Please visit www.merck-foundation.com to read more. To know more, reach out to our social media: Merck Foundation; Facebook, Twitter, Instagram, YouTube and Flicker.
Merck is a leading science and technology company in healthcare, life science and performance materials. Almost 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma.